Share on StockTwits

Tenet Healthcare Corp (NYSE: THC) received a number of ratings updates from brokerages and research firms in the last week:

  • Tenet Healthcare Corp had its price target raised by analysts at Jefferies Group from $48.00 to $63.00. They now have a “buy” rating on the stock.
  • Tenet Healthcare Corp was downgraded by analysts at Mizuho to a “buy” rating. They now have a $64.00 price target on the stock, up previously from $59.00.
  • Tenet Healthcare Corp had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a $66.00 price target on the stock, up previously from $52.00.
  • Tenet Healthcare Corp had its price target raised by analysts at Barclays from $52.00 to $66.00.
  • Tenet Healthcare Corp had its price target raised by analysts at JPMorgan Chase & Co. from $57.00 to $59.00. They now have an “overweight” rating on the stock.
  • Tenet Healthcare Corp had its “neutral” rating reaffirmed by analysts at Credit Suisse. They now have a $63.00 price target on the stock, up previously from $51.00.
  • Tenet Healthcare Corp was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $65.00 price target on the stock.

Tenet Healthcare Corp (NYSE:THC) traded up 1.25% on Wednesday, hitting $57.69. The stock had a trading volume of 1,396,069 shares. Tenet Healthcare Corp has a 52-week low of $36.87 and a 52-week high of $58.03. The stock’s 50-day moving average is $49.93 and its 200-day moving average is $45.78. The company’s market cap is $5.649 billion.

Tenet Healthcare Corporation (NYSE:THC) along with its subsidiaries, is an investor-owned health care services company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.